Thus, the reduced T-ALL burden and increased survival in Icam1-/- versus Icam1+/- mice would, if anything, underestimate the role of ICAM-1 in supporting T-ALL survival and progression. This evidence concerns the gene ICAM1 and acute lymphoblastic leukemia.